Napsin A, a New Marker for Lung Adenocarcinoma, Is Complementary and More Sensitive and Specific Than Thyroid Transcription Factor 1 in the Differential Diagnosis of Primary Pulmonary Carcinoma: Evaluation of 1674 Cases by Tissue Microarray

International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma

(2011) William D. Travis et al.   Journal of Thoracic Oncology

The Emerging Role of Histology in the Choice of First-Line Treatment of Advanced Non-Small Cell Lung Cancer: Implication in the Clinical Decision-Making

(2010) A. Rossi et al.   CURRENT MEDICINAL CHEMISTRY

Subtyping of Undifferentiated Non-small Cell Carcinomas in Bronchial Biopsy Specimens

(2010) Peh Sun Loo et al.   Journal of Thoracic Oncology

Progenitor stem cell marker expression by pulmonary carcinomas

(2010) Andre L Moreira et al.   MODERN PATHOLOGY

A study of immunohistochemical differential expression in pulmonary and mammary carcinomas

(2010) Michael Yang et al.   MODERN PATHOLOGY

Napsin A and thyroid transcription factor-1 expression in carcinomas of the lung, breast, pancreas, colon, kidney, thyroid, and malignant mesothelioma

(2009) Justin A. Bishop et al.   HUMAN PATHOLOGY

Cathepsin H and napsin A are active in the alveoli and increased in alveolar proteinosis

(2008) M. Woischnik et al.   EUROPEAN RESPIRATORY JOURNAL